Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena

6 Apr 2022

Abstract excerpt

The "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" is the third member of human coronavirus (CoV) that is held accountable for the current "coronavirus disease 2019 (COVID-19)" pandemic. In the past two decades, the world has witnessed the emergence of two other similar CoVs, namely SARS-CoV in 2002 and MERS-CoV in 2013. The extent of spread of these earlier versions was relatively low in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 epidemiological studies
Share to SARS-CoV-2 and COVID-19 Research
Share to Vaccine Coverage and Hesitancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35458489
DOI: 10.3390/v14040759

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination ArenaPMID 35458489Read ↗

Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19Semantic proximity Read ↗

Vaccine Approaches for Pandemic COVID-19Semantic proximity Read ↗

An Overview of Vaccine Development for COVID-19Semantic proximity Read ↗

Viral vectors for vaccine applicationsSemantic proximity Read ↗

Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19Semantic proximity Read ↗

Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2Semantic proximity Read ↗

VACCINES FOR COVID-19: PERSPECTIVES, PROSPECTS, AND CHALLENGES BASED ON CANDIDATE SARS, MERS, AND ANIMAL CORONAVIRUS VACCINESSemantic proximity Read ↗

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccinationSemantic proximity Read ↗

Past, Present, and Future of Viral Vector Vaccine Platforms: A Comprehensive ReviewSemantic proximity Read ↗

Replicating and non-replicating viral vectors for vaccine developmentSemantic proximity Read ↗

The use of viral vectors in vaccine developmentSemantic proximity Read ↗

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamstersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.